LIR Life Sciences Corp. (CSE:SKNY)

LIR Life Sciences Income Statement

Financials in millions CAD. Fiscal year is May - April.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Oct 31, 2025	Apr 30, 2025	Apr 30, 2024
Selling, General & Admin	0.55	0.32	0.08
Operating Expenses	0.56	0.32	0.08
Operating Income	-0.57	-0.32	-0.08
Pretax Income	-0.57	-0.32	-0.08
Net Income	-0.57	-0.32	-0.08
Net Income to Common	-0.57	-0.32	-0.08
Shares Outstanding (Basic)	15	6	0
Shares Outstanding (Diluted)	15	6	0
Shares Change (YoY)	-	42046.80%	-
EPS (Basic)	-0.04	-0.06	-6.33
EPS (Diluted)	-0.04	-0.06	-6.33
EBIT	-0.57	-0.32	-0.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.